Denosumab

Nat Rev Drug Discov. 2010 Aug;9(8):591-2. doi: 10.1038/nrd3244.
No abstract available

Publication types

  • News

MeSH terms

  • Androgen Antagonists / adverse effects
  • Androgen Antagonists / therapeutic use
  • Antibodies, Monoclonal / adverse effects
  • Antibodies, Monoclonal / pharmacology
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Bone Density / drug effects
  • Denosumab
  • Female
  • Fractures, Bone / etiology
  • Fractures, Bone / prevention & control
  • Humans
  • Male
  • Osteoporosis / complications
  • Osteoporosis / drug therapy*
  • Osteoporosis / etiology
  • Osteoporosis, Postmenopausal / complications
  • Osteoporosis, Postmenopausal / drug therapy
  • Prostatic Neoplasms / drug therapy*
  • RANK Ligand / adverse effects
  • RANK Ligand / pharmacology
  • RANK Ligand / therapeutic use*

Substances

  • Androgen Antagonists
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • RANK Ligand
  • Denosumab